Recurrence of a high-titre factor VIII inhibitor in a haemophilia A patient on emicizumab prophylaxis

被引：8

作者：

Doshi, Bhavya S. ^{[1
,2
]}

Witmer, Char M. ^{[1
,2
]}

机构：

[1] Childrens Hosp Philadelphia, Div Hematol, 3501 Civ Ctr Blvd,CTRB 5024, Philadelphia, PA 19104 USA

[2] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA

来源：

HAEMOPHILIA | 2021年 / 27卷 / 04期

关键词：

emicizumab; haemophilia A; immune tolerance; inhibitor; recurrence; IMMUNE TOLERANCE;

D O I：

10.1111/hae.14311

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E551 / E553

页数：3

共 50 条

[31] Impact of switching prophylaxis treatment from factor VIII to emicizumab in hemophilia A patients without inhibitors [J].

Escobar, Miguel ;

Agrawal, Neha ;

Chatterjee, Sagnik ;

Bhattacharya, Swastik ;

Caicedo, Jorge ;

Bullano, Michael ;

Schultz, Bob G. G. .

JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) :574-580

[32] Low-Dose Emicizumab Versus Low-/Intermediate-Dose Factor VIII Secondary Prophylaxis for Noninhibitor Haemophilia A Patients With Severe Bleeding Phenotype [J].

Kessakorn, Nuchanun ;

Gosriwatana, Itsaraet ;

Sasipong, Nuttarak ;

Srichumpuang, Chonlatis ;

Moonla, Chatphatai ;

Sosothikul, Darintr .

HAEMOPHILIA, 2025, 31 (01) :122-131

[33] Determining the approximate factor VIII level of patients with severe haemophilia A on emicizumab using in vivo global haemostasis assays [J].

Kizilocak, Hande ;

Marquez-Casas, Elizabeth ;

Malvar, Jemily ;

Carmona, Roxana ;

Young, Guy .

HAEMOPHILIA, 2021, 27 (05) :730-735

[34] Emicizumab use in females with moderate or mild hemophilia A without factor VIII inhibitors who warrant prophylaxis [J].

Hermans, Cedric ;

Ventriglia, Giuliana ;

Obaji, Samya ;

Beckermann, Benjamin M. ;

Lehle, Michaela ;

Catalani, Olivier ;

d'Oiron, Roseline ;

Frenzel, Laurent .

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (08)

[35] Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A [J].

Chalmers, E. A. ;

Brown, S. A. ;

Keeling, D. ;

Liesner, R. ;

Richards, M. ;

Stirling, D. ;

Thomas, A. ;

Vidler, V. ;

Williams, M. D. ;

Young, D. .

HAEMOPHILIA, 2007, 13 (02) :149-155

[36] Early changes in bleeding perception and quality of life in children and adolescents receiving emicizumab prophylaxis for severe haemophilia A without inhibitor [J].

Falaise, Celine ;

Roche, Martine ;

Gensollen, Sophie ;

Hezard, Nathalie ;

Boucekine, Mohamed ;

Auquier, Pascal ;

Chambost, Herve ;

Saultier, Paul .

HAEMOPHILIA, 2023, 29 (01) :397-400

[37] The effect of emicizumab prophylaxis on long-term, self-reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies [J].

Skinner, Mark W. ;

Negrier, Claude ;

Paz-Priel, Ido ;

Chebon, Sammy ;

Jimenez-Yuste, Victor ;

Callaghan, Michael U. ;

Lehle, Michaela ;

Niggli, Markus ;

Mahlangu, Johnny ;

Shapiro, Amy ;

Shima, Midori ;

Campinha-Bacote, Avrita ;

Levy, Gallia G. ;

Oldenburg, Johannes ;

von Mackensen, Sylvia ;

Pipe, Steven W. .

HAEMOPHILIA, 2021, 27 (05) :854-865

[38] Successful transfemoral prosthesis in a patient with haemophilia A and factor VIII inhibitors: A case report [J].

Chao, Ta-Chung ;

Wang, Sheng-Hao ;

Chen, Yeu-Chin ;

Li, Tsung-Ying .

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (08)

[39] Thrombotic stroke associated with the use of porcine factor VIII in a patient with acquired haemophilia [J].

Ashrani, AA ;

Reding, MT ;

Greeno, EW ;

Shet, A ;

Key, NS .

HAEMOPHILIA, 2002, 8 (01) :56-58

[40] Effectiveness of factor VIII infusions in haemophilia A patients with high responding inhibitors [J].

Kasuda, S ;

Tanaka, I ;

Shima, M ;

Matsumoto, T ;

Sakurai, Y ;

Nishiya, K ;

Giles, AR ;

Yoshioka, A .

HAEMOPHILIA, 2004, 10 (04) :341-346

← 1 2 3 4 5 →